Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastoma

Prog Clin Biol Res. 1994:385:287-91.
No abstract available

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Marrow Transplantation
  • Combined Modality Therapy
  • Humans
  • Infant
  • Neuroblastoma / drug therapy*
  • Neuroblastoma / radiotherapy*
  • Neuroblastoma / therapy
  • Prognosis
  • Risk Factors
  • Survival Analysis